Omeros reported $-39494000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Cytokinetics CYTK:US $ -86.75M 56.18M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Omeros OMER:US $ -39494000 7.82M
Regulus Therapeutics RGLS:US $ -6.72M 0.42M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Vital Therapies VTL:US $ -20.81M 0.38M
Xoma XOMA:US $ -2.28M 32.22M